Exelixis
EXEL
#1642
Rank
A$15.98 B
Marketcap
$57.99
Share price
1.17%
Change (1 day)
58.71%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $76.76 AUD on 2000-07-26

Lowest end of day price: $2.01 AUD on 2014-12-24

Stock price history of Exelixis from 2000 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$58.44 1.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
$83.44 0.98%๐Ÿ‡ซ๐Ÿ‡ท France
$124.43 1.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$75.88 0.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$436.13 0.70%๐Ÿ‡บ๐Ÿ‡ธ USA
$241.46-0.29%๐Ÿ‡บ๐Ÿ‡ธ USA
$35.50 1.74%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.46 5.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$23.38 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA